Clinical Trials Browser

Carcinoma × Erlotinib Hydrochloride × Clear all

Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT02134015 2018-01-23

HER3-Lung

Bronchial Neoplasms, Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Site, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

NCT00737243 2016-08-17

Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site

Phase 2 Completed

289 enrolled 5 charts

Tumor-Agnostic

Carcinoma

NCT00673049 2013-07-24

NSCLC

Phase 3 Terminated

583 enrolled 11 charts

Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Carcinoma, Large Cell

NCT00908336 2009-05-25

Erlotinib and Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Failure of One Chemotherapy Regimen

Phase 2 Unknown

70 enrolled

Thoracic

Adenocarcinoma, Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Clinical Trials

Study of Tarceva and Targretin in Stage I-II Lung Cancer

HER3-Lung

Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site

NSCLC

Erlotinib and Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Failure of One Chemotherapy Regimen